John Renger - Net Worth and Insider Trading

John Renger Net Worth

The estimated net worth of John Renger is at least $286,395 dollars as of 2024-11-05. John Renger is the Chief Scientific Officer of Cerevel Therapeutics Holdings Inc and owns about 6,370 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $286,395. Details can be seen in John Renger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Renger has not made any transactions after 2024-02-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John Renger

To

John Renger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Renger owns 1 companies in total, including Cerevel Therapeutics Holdings Inc (CERE) .

Click here to see the complete history of John Renger’s form 4 insider trades.

Insider Ownership Summary of John Renger

Ticker Comapny Transaction Date Type of Owner
CERE Cerevel Therapeutics Holdings Inc 2024-02-07 Chief Scientific Officer

John Renger Latest Holdings Summary

John Renger currently owns a total of 1 stock. John Renger owns 6,370 shares of Cerevel Therapeutics Holdings Inc (CERE) as of February 7, 2024, with a value of $286,395.

Latest Holdings of John Renger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CERE Cerevel Therapeutics Holdings Inc 2024-02-07 6,370 44.96 286,395

Holding Weightings of John Renger


John Renger Form 4 Trading Tracker

According to the SEC Form 4 filings, John Renger has made a total of 17 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 2,161 shares on February 7, 2024, which brought John Renger around $89,768.

Insider Trading History of John Renger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Renger Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Renger Ownership Network

Ownership Network List of John Renger

No Data

Ownership Network Relation of John Renger

Insider Network Chart

John Renger Owned Company Details

What does Cerevel Therapeutics Holdings Inc do?

Who are the key executives at Cerevel Therapeutics Holdings Inc?

John Renger is the Chief Scientific Officer of Cerevel Therapeutics Holdings Inc. Other key executives at Cerevel Therapeutics Holdings Inc include director & See Remarks N Anthony Coles , Chief Medical Officer Ramiro Sanchez , and Chief Human Resources Officer Kenneth Dipietro .

Cerevel Therapeutics Holdings Inc (CERE) Insider Trades Summary

Over the past 18 months, John Renger made no insider transaction in Cerevel Therapeutics Holdings Inc (CERE). Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 627,506 shares made by N Anthony Coles , a net sale of 37,652 shares made by Ramiro Sanchez , and a net sale of 24,572 shares made by Scott Akamine .

In summary, during the past 3 months, insiders sold 0 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 966,157 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 17,422,701 shares were bought by its insiders, resulting in a net purchase of 16,456,544 shares.

Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cerevel Therapeutics Holdings Inc Insider Transactions

No Available Data

John Renger Mailing Address

Above is the net worth, insider trading, and ownership report for John Renger. You might contact John Renger via mailing address: C/o Cerevel Therapeutics, Inc., 51 Ashtor Place, New York Ny 10003.